A man who recently traveled from a country that has reported Mpox is in isolation in a hospital in India, and samples taken are awaiting tests. The Ministry of Health has sought to allay the citizens’ fears by telling them not to panic.
The Centre said that the young male patient has improved, and the case is now considered as a suspect. Samples are currently being tested while contact tracing is done to determine the origin and possible effects in the country.
This case falls in tandem with previous risk analyses done by the National Centre for Disease Control (NCDC). WHO classified Mpox as a public health emergency of international concern in the middle of the current month, suggesting that 120+ nations were affected, with more than a hundred thousand cases confirmed between January and August this year.
Dr. Atul Goel, Director General of Health Services, spelled out some symptoms that include fever, rashes, swollen lymph nodes, and fatigue. Mpox is a zoonotic disease primarily transmitted through direct contact and not airborne, as is the case with the flu or COVID-19.
Currently, there is no specific drug for the virus, but treatment for other similar viruses might work. Vaccination can prevent an epidemic, and vaccines can be given as post-exposure prophylaxis in certain time intervals.
